Odyssey Therapeutics, Inc. (ODTX) stock
ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026
$19.37+0.01 (+0.05%)
Close on Nov 17, 2026Market cap $930.89MP/E –Yield –
Odyssey Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for Odyssey Therapeutics
Odyssey Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?